When AI designs a drug, who gets the credit?
When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up

with drug ideas humans might never think…
Key Takeaways
- •Latest on When AI designs a drug, who gets the credit? — reported by MIT Tech Review for the tech space.
- •This story was reported by MIT Tech Review, covering developments in the tech space.
- •AI advancements continue to reshape industries — read the full article on MIT Tech Review for complete coverage.
📖 Continue reading the full article:
Read Full Article on MIT Tech Review →


